Genkyotex SA is a biopharmaceutical company. It is engaged in the business of research, study, manufacturing and distribution of medicines, drug and health products in the field of human and animal health. The firm is involved in the development of immunotherapies and therapeutic vaccines designed to treat women for cervical cancer. Its products include vaxiclase technological platform and GTL001 and GTL002. The company has the Development of immunotherapies segment.